NEET-SS 2023

📚 01 General Pediatrics • 🎯 27 High-Yield MCQs • Nelson 22nd Edition Standard

Hepatobiliary & Metabolic Syndromes

  • Alagille Syndrome: ((GP23001)): Autosomal dominant multisystem disorder caused by intrahepatic bile duct paucity. Characterized by triangular facies (broad forehead, deep-set eyes, bulbous nasal tip, pointed chin), cardiac defects (most commonly peripheral pulmonary artery stenosis), ophthalmologic findings (posterior embryotoxon), and skeletal abnormalities (butterfly vertebrae).
  • Laron Syndrome: ((GP23002)): Autosomal recessive disorder resulting from growth hormone receptor mutations leading to GH resistance and markedly low IGF-1 levels despite normal/elevated GH levels. Features include severe postnatal growth retardation, prominent forehead, depressed nasal bridge, and short limbs.
  • Abetalipoproteinemia: ((((GP23003)) · ((GP23006)))): Autosomal recessive disorder due to MTTP gene mutations causing deficiency of microsomal triglyceride transfer protein. Results in absence of chylomicrons, VLDL, and LDL, very low cholesterol/triglycerides, fat malabsorption, steatorrhea, failure to thrive, ataxia, peripheral neuropathy, and retinitis pigmentosa.

Chromosomal Disorders & Syndromes

  • Down Syndrome (Trisomy 21): ((((GP23003)) · ((GP23004)) · ((GP23005)) · ((GP23022)))): Most commonly caused by maternal meiotic nondisjunction (~95%). A Robertsonian translocation carrier state involving `t(21;21)` carries a 100% recurrence risk for offspring. Complications include congenital heart disease, hypothyroidism, and Transient Abnormal Myelopoiesis (TAM) in neonates linked to somatic GATA1 mutations in blasts. Children with congenital heart disease or post-operative cardiac surgery presenting with advanced second-degree or complete AV block require a permanent pacemaker.
  • Turner Syndrome: ((GP23009)): Characterized by a 45,X0 karyotype, short stature, and gonadal dysgenesis. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome features Müllerian agenesis with 46,XX (not 46,XY) karyotype and normal ovarian function. Swyer syndrome presents with 46,XY complete gonadal dysgenesis.
  • Ellis–Van Creveld Syndrome: ((GP23010)): Chondroectodermal dysplasia presenting with the classic triad of short stature, polydactyly, and congenital heart disease (most commonly common atrium / atrial septal defect), alongside dysplastic nails, teeth, and a narrow thorax.
  • Prader–Willi Syndrome: ((GP23015)): Caused by lack of expression of paternally inherited genes on chromosome 15q11–q13 (via paternal deletion or maternal uniparental disomy). Features severe neonatal hypotonia, rapid-onset obesity, hyperphagia, hypogonadism, and compulsive skin-picking behavior.

Genetics, Tumors & Neurocutaneous Disorders

  • Retinoblastoma: ((GP23007)): The most common intraocular childhood malignancy, inherited in an autosomal dominant pattern via germline mutations in the RB1 tumor suppressor gene (chromosome 13q14) following the two-hit hypothesis.
  • Ataxia Telangiectasia: ((GP23008)): Autosomal recessive multisystem disorder caused by ATM gene mutations. Features progressive cerebellar ataxia, oculocutaneous telangiectasias, immunodeficiency, and high radiosensitivity.
  • Menkes Disease: ((GP23011)): X-linked recessive neurodegenerative disorder caused by ATP7A mutations leading to copper and ceruloplasmin deficiency. Manifests with hypotonia, seizures, failure to thrive, and sparse, brittle, twisted hair (pili torti).
  • Neurofibromatosis Type 1 (NF1): ((GP23026)): Associated most frequently with optic nerve gliomas (present in 15–20% of cases, commonly symptomatic between ages 2 and 6 years).

Developmental Milestones & Immunization Catch-Up

  • 18-Month Developmental Milestones: ((GP23012)): Gross motor: runs stiffly, walks up stairs with one hand held. Fine motor: builds a tower of 3–4 cubes, imitates scribbling, draws a horizontal line (not yet circular strokes). Language: ~10-word vocabulary.
  • Childhood Catch-Up Immunization Rules: ((((GP23013)) · ((GP23014)))):
  • BCG and Rotavirus: : Contraindicated / not given beyond infancy (do not restart/catch up in unimmunized toddlers).
  • DPT and OPV: : Administer missed primary doses at 1-month intervals, followed by a booster at least 6 months later.
  • PCV: : Children aged 12–24 months with no prior doses require 2 doses 8 weeks apart; children 12–59 months require a single dose.
  • Measles: : Administer the first dose immediately, with the second dose at least 4 weeks later along with Vitamin A supplementation (2 mL).

Nutrition, Deficiencies & Toxicity

  • Niacin (Vitamin B3) Deficiency: ((GP23017)): Causes pellagra, classic for the 3 D's (Dermatitis, Diarrhea, Dementia) and presenting with a characteristic Casal necklace (sun-exposed, hyperpigmented, scaly collar rash).
  • Zinc Deficiency: ((GP23018)): Causes acrodermatitis enteropathica via SLC39A4 mutations, manifesting with vesiculobullous/psoriasiform lesions in perioral, acral, and perineal distributions alongside alopecia and a reddish hair tint.
  • Selenium Deficiency: ((GP23019)): Causes Keshan disease, characterized by endemic dilated cardiomyopathy and heart failure due to impaired cellular antioxidant defense (glutathione peroxidase).
  • Vitamin E Toxicity: ((GP23020)): Excess supplementation causes an increased bleeding risk (hemorrhages, hemorrhagic stroke), significantly potentiating the effect of concurrent anticoagulation or antiplatelet agents.
  • Refeeding Syndrome: ((GP23021)): Characterized by severe electrolyte shifts upon re-feeding malnourished patients, with hypophosphatemia (<3.0 mg/dL) being the primary driver of ATP depletion and congestive heart failure-like cardiac dysfunction.

Critical Care, Rheumatology & Enzyme Replacement

  • Brain Death Determination: ((GP23023)): Confirmatory ancillary testing with an EEG must demonstrate electrocerebral silence over a 30-minute recording.
  • Macrophage Activation Syndrome (MAS): ((GP23024)): A life-threatening secondary HLH complication of systemic juvenile idiopathic arthritis (sJIA). Characterized by persistent spiking fever, hepatosplenomegaly, lymphadenopathy, encephalopathy, thrombocytopenia, hypofibrinogenemia, elevated liver enzymes, and a paradoxically low ESR.
  • Enzyme Replacement Therapy (ERT): ((GP23025)): In Gaucher disease (recombinant acid β-glucosidase / imiglucerase), the patient's antibody response does not affect treatment efficacy, unlike Pompe disease or PKU.
  • Tumor Lysis Syndrome (TLS): ((GP23027)): Characterized by massive intracellular release of nucleic acids, potassium, and phosphorus after chemotherapy initiation, resulting in hyperuricemia, hyperkalemia, and hyperphosphatemia. Hypercalcemia is absent; instead, hypocalcemia occurs due to calcium binding by excess phosphate.